Leisure Capital Management’s VolitionRx Ltd VNRX Stock Holding History

Leisure Capital Management’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-663	Closed	-$42K	–	117
2019 Q2	$42K	Sell	663 -2,804	-81%	-$182K	0.04%	110
2019 Q1	$225K	Buy	3,467 +149	+4%	+$8.32K	0.19%	112
2018 Q4	$120K	Sell	3,318 -306	-8%	-$14.6K	0.11%	116
2018 Q3	$188K	Buy	+3,624	New	+$149K	0.15%	121
2018 Q2	–	Sell	-3,674	Closed	-$176K	–	140
2018 Q1	$176K	Sell	3,674 -69	-2%	-$4.04K	0.15%	132
2017 Q4	$220K	Buy	3,743 +81	+2%	+$4.74K	0.18%	96
2017 Q3	$193K	Buy	+3,662	New	+$215K	0.17%	96

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 27.61% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Leisure Capital Management's VNRX Position: Q3 2019 in Review

Leisure Capital Management sold out of VolitionRx Ltd (VNRX) in Q3 2019, closing a stake of 663 shares — an estimated $42K sold.

Leisure Capital Management first reported a position in VNRX in Q3 2017 and held it in 7 quarters. The position peaked at $225K in Q1 2019. 31 funds tracked by Wall St. Rank hold VNRX as of Q3 2019.

Leisure Capital Management reported no remaining VolitionRx Ltd position as of Q3 2019 after selling out during the quarter.
Leisure Capital Management sold 663 VolitionRx Ltd shares in Q3 2019, an estimated $42K.
Leisure Capital Management first reported a position in VolitionRx Ltd in Q3 2017 and held it in 7 quarters.
Leisure Capital Management's VolitionRx Ltd position peaked at $225K in Q1 2019.
31 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q3 2019.

Based on Leisure Capital Management's 13F filing for Q3 2019, filed 8 Nov 2019.